-
1
-
-
77249096441
-
Whole-animal imaging: The whole picture
-
Baker M. Whole-animal imaging: the whole picture. Nature 2010;463:977-80.
-
(2010)
Nature
, vol.463
, pp. 977-980
-
-
Baker, M.1
-
2
-
-
33645798851
-
The fluorescent toolbox for assessing protein location and function
-
Giepmans BNG, Adams SR, Ellisman MH, Tsien RY. The fluorescent toolbox for assessing protein location and function. Science 2006;312:217-24.
-
(2006)
Science
, vol.312
, pp. 217-224
-
-
Giepmans, B.N.G.1
Adams, S.R.2
Ellisman, M.H.3
Tsien, R.Y.4
-
3
-
-
0030700632
-
Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
-
Neri D, Carnemolla B, Nissim A, Leprini A, Querzè G, Balza E, et al. Targeting by affinity-matured recombinent antibody fragments of an angiogenesis-associated fibronectin isoform. Nat Biotechnol 1997;15:1271-5. (Pubitemid 27465138)
-
(1997)
Nature Biotechnology
, vol.15
, Issue.12
, pp. 1271-1275
-
-
Neri, D.1
Carnemolla, B.2
Nissim, A.3
Leprini, A.4
Querze, G.5
Balza, E.6
Pini, A.7
Tarli, L.8
Halin, C.9
Neri, P.10
Zardi, L.11
Winter, G.12
-
4
-
-
0034256860
-
Macromolecular contrast agents for optical imaging of tumors: Comparison of indotricarbocyanine-labeled human serum albumin and transferin
-
Becker A, Riefke B, Ebert B, Sukowski U, Rinneberg H, Semmler W, et al. Macromolecular contrast agents for optical imaging of tumors: comparison of indotricarbocyanine-labeled human serum albumin and transferin. Photochem Photobiol 2000;72:234-41.
-
(2000)
Photochem Photobiol
, vol.72
, pp. 234-241
-
-
Becker, A.1
Riefke, B.2
Ebert, B.3
Sukowski, U.4
Rinneberg, H.5
Semmler, W.6
-
5
-
-
0036066218
-
Fluorescence molecular tomography resolves protease activity in vivo
-
DOI 10.1038/nm729
-
Ntziachristos V, Tung C-H, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protesase activity in vivo. Nat Med 2002;8;757-60. (Pubitemid 34778731)
-
(2002)
Nature Medicine
, vol.8
, Issue.7
, pp. 757-760
-
-
Ntziachristos, V.1
Tung, C.-H.2
Bremer, C.3
Weissleder, R.4
-
6
-
-
33644825565
-
Dynamic imaging of protease activity with fluorescently quenched activity-based probes
-
Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, Rice MJ, et al. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol 2005;1:203-9.
-
(2005)
Nat Chem Biol
, vol.1
, pp. 203-209
-
-
Blum, G.1
Mullins, S.R.2
Keren, K.3
Fonovic, M.4
Jedeszko, C.5
Rice, M.J.6
-
7
-
-
20344367518
-
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression
-
DOI 10.1073/pnas.0503500102
-
Achilefu S, Bloch S, Markiewicz MA, Zhong T, Ye Y, DorshowRB, et al. Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc Natl Acad Sci U S A 2005;102:7976-81. (Pubitemid 40781048)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.22
, pp. 7976-7981
-
-
Achilefu, S.1
Bloch, S.2
Markiewicz, M.A.3
Zhong, T.4
Ye, Y.5
Dorshow, R.B.6
Chance, B.7
Liang, K.8
-
8
-
-
0032483712
-
Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)
-
Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Can Inst 1998;90:1529-36.
-
(1998)
J Natl Can Inst
, vol.90
, pp. 1529-1536
-
-
Taketo, M.M.1
-
9
-
-
0030461132
-
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
-
Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996;384:644-8.
-
(1996)
Nature
, vol.384
, pp. 644-648
-
-
Kurumbail, R.G.1
Stevens, A.M.2
Gierse, J.K.3
McDonald, J.J.4
Stegeman, R.A.5
Pak, J.Y.6
-
10
-
-
0034721194
-
Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors
-
DOI 10.1021/jm000004e
-
Kalgutkar AS, Marnett AB, Crews BC, Remmel RP, Marnett LJ. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors. J Med Chem 2000;43:2860-70. (Pubitemid 30599644)
-
(2000)
Journal of Medicinal Chemistry
, vol.43
, Issue.15
, pp. 2860-2870
-
-
Kalgutkar, A.S.1
Marnett, A.B.2
Crews, B.C.3
Remmel, R.P.4
Marnett, L.J.5
-
11
-
-
13444266910
-
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib)
-
Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40:1347-75.
-
(1997)
J Med Chem
, vol.40
, pp. 1347-1375
-
-
Penning, T.D.1
Talley, J.J.2
Bertenshaw, S.R.3
Carter, J.S.4
Collins, P.W.5
Docter, S.6
-
12
-
-
77951738107
-
Selective visualization of cyclooxygenase-2 in inflammation and cancer withtargetedimaging agents
-
Uddin MJ, Crews BC, Blobaum AL, Kingsley PJ, Gorden DL, McIntyre JO, et al. Selective visualization of cyclooxygenase-2 in inflammation and cancer withtargetedimaging agents.CancerRes 2010;70:3618-27.
-
(2010)
CancerRes
, vol.70
, pp. 3618-3627
-
-
Uddin, M.J.1
Crews, B.C.2
Blobaum, A.L.3
Kingsley, P.J.4
Gorden, D.L.5
McIntyre, J.O.6
-
17
-
-
0027515708
-
Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane
-
Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiol 1993;79:795-807. (Pubitemid 23296712)
-
(1993)
Anesthesiology
, vol.79
, Issue.4
, pp. 795-807
-
-
Kharasch, E.D.1
Thummel, K.E.2
-
18
-
-
0343942487
-
Indomethacin: A new non-steroid anti-inflammatory agent
-
Hart FD, Boardman PL. Indomethacin: a new non-steroid anti-inflammatory agent. Br Med J 1963;5363:965-70.
-
(1963)
Br Med J
, vol.5363
, pp. 965-970
-
-
Hart, F.D.1
Boardman, P.L.2
-
19
-
-
0033526928
-
The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4'- methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor
-
DOI 10.1016/S0960-894X(99)00288-7, PII S0960894X99002887
-
Prasit P, Wang Z, Brideau C, Chan CC, Charleson S, Cromlish W, et al. The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)- 3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor. Bioorg Med Chem Lett 1999;9:1773-8. (Pubitemid 29287387)
-
(1999)
Bioorganic and Medicinal Chemistry Letters
, vol.9
, Issue.13
, pp. 1773-1778
-
-
Prasit, P.1
Wang, Z.2
Brideau, C.3
Chan, C.-C.4
Charleson, S.5
Cromlish, W.6
Ethier, D.7
Evans, J.F.8
Ford-Hutchinon, A.W.9
Gauthier, J.Y.10
Gordon, R.11
Guay, J.12
Gresser, M.13
Kargman, S.14
Kennedy, B.15
Leblanc, Y.16
Leger, S.17
Mancini, J.18
O'Neill, G.P.19
Ouellet, M.20
Percival, M.D.21
Perrier, H.22
Riendeau, D.23
Rodger, I.24
Tagari, P.25
Therien, M.26
Vickers, P.27
Wong, E.28
Xu, L.-J.29
Young, R.N.30
Zamboni, R.31
Boyce, S.32
Rupniak, N.33
Forrest, M.34
Visco, D.35
Patrick, D.36
more..
-
20
-
-
0034681109
-
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors
-
DOI 10.1073/pnas.97.2.925
-
Kalgutkar AS, Crews BC, Rowlinson SW, Marnett AB, Kozak KR, Remmel RP, et al. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal anti-inflammatory drugs to potent and highly selective COX-2 inhibitors. Proc Natl Acad Sci U S A 2000;97:925-30. (Pubitemid 30070411)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.2
, pp. 925-930
-
-
Kalgutkar, A.S.1
Crews, B.C.2
Rowlinson, S.W.3
Marnett, A.B.4
Kozak, K.R.5
Remmel, R.P.6
Marnett, L.J.7
-
21
-
-
0032548140
-
Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators
-
DOI 10.1021/jm980303s
-
Kalgutkar AS, Kozak KR, Crews BC, Hochgesang GP, Marnett LJ. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators. J Med Chem 1998;41:4800-18. (Pubitemid 28530456)
-
(1998)
Journal of Medicinal Chemistry
, vol.41
, Issue.24
, pp. 4800-4818
-
-
Kalgutkar, A.S.1
Kozak, K.R.2
Crews, B.C.3
Hochgesang Jr., G.P.4
Marnett, L.J.5
-
22
-
-
0028818913
-
Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
-
Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995;378:406-9.
-
(1995)
Nature
, vol.378
, pp. 406-409
-
-
Dinchuk, J.E.1
Car, B.D.2
Focht, R.J.3
Johnston, J.J.4
Jaffee, B.D.5
Covington, M.B.6
-
23
-
-
0242409499
-
AMIDE: A free software tool for multi-modality medical image analysis
-
Loening AM, Gambhir SS. AMIDE: a free software tool for multi-modality medical image analysis. Mol Imaging 2003;2:131-37.
-
(2003)
Mol Imaging
, vol.2
, pp. 131-137
-
-
Loening, A.M.1
Gambhir, S.S.2
-
24
-
-
67249094291
-
Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs
-
Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med 1962;111:544-7.
-
(1962)
Proc Soc Exp Biol Med
, vol.111
, pp. 544-547
-
-
Winter, C.A.1
Risley, E.A.2
Nuss, G.W.3
-
25
-
-
39749149266
-
Eicosanoid modulation in advanced lung cancer: Cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy - Cancer and leukemia group B trial 30203
-
DOI 10.1200/JCO.2007.13.8081
-
Edelman MJ, Watson D, Wang X, Morrison C, Kratzke RA, Jewell S, et al. Eicosanoid modulation in advanced lung cancer: cycloxygenase-2 expression is a positive predictive factor, for celecoxib + chemotherapy-Cancer and Leukemia Group B trial 30203. J Clin Oncol 2008;26,848-55. (Pubitemid 351398075)
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.6
, pp. 848-855
-
-
Edelman, M.J.1
Watson, D.2
Wang, X.3
Morrison, C.4
Kratzke, R.A.5
Jewell, S.6
Hodgson, L.7
Mauer, A.M.8
Gajra, A.9
Masters, G.A.10
Bedor, M.11
Vokes, E.E.12
Green, M.J.13
|